LENSAR makes laser systems for cataract surgery and corneal astigmatism, sold to eye surgeons and surgery centers. LNSR reports earnings on Thu, Nov 12, 2026.
Earnings
Earnings calendar →Analyst Ratings & Price Targets
Analyst Ratings →| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Sep 28 | LUCID CAPITAL MARKETS | Initiated | Buy | |
| Aug 13 | BTIG | Target lowered | Buy | |
| Mar 18 | BTIG | Upgrade | Buy |
Seasonality
How LNSR has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2020.
Whale Options Flow
90DNo whale options trades in LNSR in the last 90 days.
AI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether LNSR is in one of them and how their past LNSR trades turned out.
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered LNSR in an article yet. Here's the latest on the wider market.
About LENSAR
LENSAR makes laser systems used in cataract surgery and in treating astigmatism, which is an uneven curve of the cornea that can blur vision. Its main products are the LENSAR Laser System and the ALLY Robotic Cataract Laser System, which help surgeons plan procedures, make incisions, and break up the cloudy lens. Its customers are eye surgeons and ambulatory surgery centers, and the company is based in Orlando, Florida.
- Headquarters
- Orlando, FL